Guilin Sanjin Pharmaceutical Co., Ltd. Class ASZSE: 002275

Guilin Sanjin Pharmaceutical Co., Ltd. Class A AGM RESOLUTION 2026-04-24

· Issued by Guilin Sanjin Pharmaceutical Co., Ltd. Class A via Shenzhen Stock Exchange
The Company held its Annual General Meeting of 2025 on 23 April 2026, during which the following proposal(s) was/were approved:
1. 2025 work report of independent directors
2. 2025 annual report and its summary
3. 2025 annual accounts report
4. 2025 profit distribution plan
5. Reappointment of audit firm
6. Bank credit and loans
7. By-election of non-independent directors

The detailed profit distribution plan is as follows:
1) Cash dividend/10 shares (tax included): CNY1.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Company analysis

Earlier from Guilin Sanjin Pharmaceutical Co., Ltd. Class A

All Guilin Sanjin Pharmaceutical Co., Ltd. Class A news releases